346 related articles for article (PubMed ID: 33340428)
1. MCM10 compensates for Myc-induced DNA replication stress in breast cancer stem-like cells.
Murayama T; Takeuchi Y; Yamawaki K; Natsume T; Li M; Marcela RN; Nishimura T; Kogure Y; Nakata A; Tominaga K; Sasahara A; Yano M; Ishikawa S; Ohta T; Ikeda K; Horie-Inoue K; Inoue S; Seki M; Suzuki Y; Sugano S; Enomoto T; Tanabe M; Tada KI; Kanemaki MT; Okamoto K; Tojo A; Gotoh N
Cancer Sci; 2021 Mar; 112(3):1209-1224. PubMed ID: 33340428
[TBL] [Abstract][Full Text] [Related]
2. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.
Yang A; Qin S; Schulte BA; Ethier SP; Tew KD; Wang GY
Cancer Res; 2017 Dec; 77(23):6641-6650. PubMed ID: 28951456
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
4. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
5. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
6. Over-Activation of Minichromosome Maintenance Protein 10 Promotes Genomic Instability in Early Stages of Breast Cancer.
Mughal MJ; Chan KI; Mahadevappa R; Wong SW; Wai KC; Kwok HF
Int J Biol Sci; 2022; 18(9):3827-3844. PubMed ID: 35813483
[TBL] [Abstract][Full Text] [Related]
7. The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing.
Izumi M; Mizuno T; Yanagi KI; Sugimura K; Okumura K; Imamoto N; Abe T; Hanaoka F
J Biol Chem; 2017 Aug; 292(31):13008-13021. PubMed ID: 28646110
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Wang M; Xie S; Yuan W; Xie T; Jamal M; Huang J; Yin Q; Song H; Zhang Q
Int J Oncol; 2019 Dec; 55(6):1349-1360. PubMed ID: 31638210
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
10. MCM10 facilitates the invaded/migrated potentials of breast cancer cells via Wnt/β-catenin signaling and is positively interlinked with poor prognosis in breast carcinoma.
Yang WD; Wang L
J Biochem Mol Toxicol; 2019 Jul; 33(7):e22330. PubMed ID: 30990947
[TBL] [Abstract][Full Text] [Related]
11. Novel roles of HP1a and Mcm10 in DNA replication, genome maintenance and photoreceptor cell differentiation.
Vo N; Anh Suong DN; Yoshino N; Yoshida H; Cotterill S; Yamaguchi M
Nucleic Acids Res; 2017 Feb; 45(3):1233-1254. PubMed ID: 28180289
[TBL] [Abstract][Full Text] [Related]
12. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract][Full Text] [Related]
13. Interaction of RECQ4 and MCM10 is important for efficient DNA replication origin firing in human cells.
Kliszczak M; Sedlackova H; Pitchai GP; Streicher WW; Krejci L; Hickson ID
Oncotarget; 2015 Dec; 6(38):40464-79. PubMed ID: 26588054
[TBL] [Abstract][Full Text] [Related]
14. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
15. The N-terminus of Mcm10 is important for interaction with the 9-1-1 clamp and in resistance to DNA damage.
Alver RC; Zhang T; Josephrajan A; Fultz BL; Hendrix CJ; Das-Bradoo S; Bielinsky AK
Nucleic Acids Res; 2014 Jul; 42(13):8389-404. PubMed ID: 24972833
[TBL] [Abstract][Full Text] [Related]
16. Enigmatic roles of Mcm10 in DNA replication.
Thu YM; Bielinsky AK
Trends Biochem Sci; 2013 Apr; 38(4):184-94. PubMed ID: 23332289
[TBL] [Abstract][Full Text] [Related]
17. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
[TBL] [Abstract][Full Text] [Related]
18. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Tanioka M; Mott KR; Hollern DP; Fan C; Darr DB; Perou CM
Genome Med; 2018 Nov; 10(1):86. PubMed ID: 30497520
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of Myc in stem cell biology and novel tumor therapies.
Yoshida GJ
J Exp Clin Cancer Res; 2018 Jul; 37(1):173. PubMed ID: 30053872
[TBL] [Abstract][Full Text] [Related]
20. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
